Literature DB >> 19684494

Denial and acceptance coping styles and medication adherence in schizophrenia.

Stephanie Aldebot1, Amy G Weisman de Mamani.   

Abstract

Antipsychotics are often the first line of treatment for individuals with schizophrenia (). One challenge to effective treatment is lack of adherence to prescribed medication. Lower rates of adherence are associated with considerably higher rates of relapse and poorer course of illness. Therefore studying the characteristics that may be related to medication adherence is important. Coping styles may be one such factor. Individuals use a variety of coping mechanisms to manage and navigate difficult life events, including mental illness (). In the present study, 40 individuals with schizophrenia were assessed regarding their coping styles and medication adherence practices. As hypothesized, it was found that denial coping was inversely related to medication adherence. However, contrary to expectations, acceptance coping was not related to medication adherence. These findings suggest that targeting denial coping strategies in treatment may help foster more optimal strategies for managing schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19684494      PMCID: PMC2747048          DOI: 10.1097/NMD.0b013e3181b05fbe

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  37 in total

1.  Insight and cognitive deficits in schizophrenia: evidence for a curvilinear relationship.

Authors:  M Startup
Journal:  Psychol Med       Date:  1996-11       Impact factor: 7.723

2.  Assessing coping strategies: a theoretically based approach.

Authors:  C S Carver; M F Scheier; J K Weintraub
Journal:  J Pers Soc Psychol       Date:  1989-02

3.  Dynamics of a stressful encounter: cognitive appraisal, coping, and encounter outcomes.

Authors:  S Folkman; R S Lazarus; C Dunkel-Schetter; A DeLongis; R J Gruen
Journal:  J Pers Soc Psychol       Date:  1986-05

4.  Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.

Authors:  Jeffrey A Lieberman; T Scott Stroup; Joseph P McEvoy; Marvin S Swartz; Robert A Rosenheck; Diana O Perkins; Richard S E Keefe; Sonia M Davis; Clarence E Davis; Barry D Lebowitz; Joanne Severe; John K Hsiao
Journal:  N Engl J Med       Date:  2005-09-19       Impact factor: 91.245

5.  Coping-skills training versus a problem-solving approach with schizophrenic patients.

Authors:  W H Bradshaw
Journal:  Hosp Community Psychiatry       Date:  1993-11

6.  Coping with hallucinations: exploring stress and coping framework.

Authors:  J Farhall; M Gehrke
Journal:  Br J Clin Psychol       Date:  1997-05

7.  Further parameters of insight and neuropsychological deficit in schizophrenia and other chronic mental disease.

Authors:  D A Young; K K Zakzanis; C Bailey; R Davila; J Griese; G Sartory; A Thom
Journal:  J Nerv Ment Dis       Date:  1998-01       Impact factor: 2.254

8.  Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder.

Authors:  D Robinson; M G Woerner; J M Alvir; R Bilder; R Goldman; S Geisler; A Koreen; B Sheitman; M Chakos; D Mayerhoff; J A Lieberman
Journal:  Arch Gen Psychiatry       Date:  1999-03

9.  Training and quality assurance with the Structured Clinical Interview for DSM-IV (SCID-I/P).

Authors:  J Ventura; R P Liberman; M F Green; A Shaner; J Mintz
Journal:  Psychiatry Res       Date:  1998-06-15       Impact factor: 3.222

10.  Interpersonal problem solving and information processing in schizophrenia.

Authors:  P W Corrigan; R Toomey
Journal:  Schizophr Bull       Date:  1995       Impact factor: 9.306

View more
  8 in total

1.  Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review.

Authors:  Kyoko Higashi; Goran Medic; Kavi J Littlewood; Teresa Diez; Ola Granström; Marc De Hert
Journal:  Ther Adv Psychopharmacol       Date:  2013-08

2.  Medication Adherence and Coping Strategies in Patients with Rheumatoid Arthritis: A Cross-Sectional Study.

Authors:  Carolin Berner; Ludwig Erlacher; Karl H Fenzl; Thomas E Dorner
Journal:  Int J Rheumatol       Date:  2019-03-04

3.  The SPUR Model: A Framework for Considering Patient Behavior.

Authors:  Kevin Dolgin
Journal:  Patient Prefer Adherence       Date:  2020-01-16       Impact factor: 2.711

4.  Factors associated with dropout at 2 years post-initiation of treatment in the first episode of schizophrenia.

Authors:  Jebril M Benelmokhtar; Bonginkosi Chiliza; Lebogang Phahladira; Robin Emsley; Laila Asmal
Journal:  S Afr J Psychiatr       Date:  2021-03-09       Impact factor: 1.550

5.  Stress Impact of COVID-19 Sports Restrictions on Disabled Athletes.

Authors:  Giovanni Fiorilli; Andrea Buonsenso; Nicola Davola; Giulia Di Martino; Francesca Baralla; Stefanos Boutious; Marco Centorbi; Giuseppe Calcagno; Alessandra di Cagno
Journal:  Int J Environ Res Public Health       Date:  2021-11-16       Impact factor: 3.390

6.  Coping strategies and quality of life in schizophrenia: cross-sectional study.

Authors:  Michaela Holubova; Jan Prasko; Radovan Hruby; Dana Kamaradova; Marie Ociskova; Klara Latalova; Ales Grambal
Journal:  Neuropsychiatr Dis Treat       Date:  2015-12-10       Impact factor: 2.570

7.  Self-Efficacy and Adherence Behaviors in Rheumatoid Arthritis Patients.

Authors:  Christiana Oshotse; Leah L Zullig; Hayden B Bosworth; Pikuei Tu; Cheryl Lin
Journal:  Prev Chronic Dis       Date:  2018-10-18       Impact factor: 2.830

8.  Influence of an inconsistent appearance of antipsychotics on drug adherence in patients with schizophrenia.

Authors:  Unax Lertxundi; Rafael Hernandez; Beatriz Corcóstegui; Olatz Ibarra; Gorka Mentxaka; Juan Medrano
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.